| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $804.2M | — | +26.1% |
| Cost of Revenue | $359.1M | — | +26.3% |
| Gross Profit | $445.1M | — | +26.0% |
| R&D Expense | $100.6M | — | +9.0% |
| SG&A Expense | $103.3M | — | +12.0% |
| Operating Income | $241.2M | — | +42.9% |
| Pre-tax Income | $247.2M | — | +42.1% |
| Income Tax | $54.0M | — | +34.6% |
| Net Income | $193.2M | — | +44.4% |
| EPS (Basic) | $3.94 | — | +40.7% |
| EPS (Diluted) | $3.92 | — | +40.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.06B | -3.3% | +66.8% |
| Short-term Investments | $304.2M | +93.4% | -21.9% |
| Accounts Receivable | $302.1M | +18.2% | +40.6% |
| Inventory | $619.2M | +9.7% | +36.1% |
| Current Assets | $2.33B | +6.7% | +30.3% |
| Total Assets | $4.45B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $250.3M | — | -2.4% |
| Capital Expenditures | $70.8M | — | +75.6% |
| Investing Cash Flow | -$212.3M | — | +17.5% |
| Financing Cash Flow | -$75.3M | — | -34.6% |
| Free Cash Flow | $179.4M | — | -17.0% |
| +16.9% |
| Current Liabilities | $487.0M | +31.8% | +34.0% |
| Total Liabilities | $771.5M | +16.4% | +43.2% |
| Stockholders' Equity | $3.68B | +4.1% | +12.6% |